Shinobi Therapeutics
shinobitx.comLocations
South San Francisco, CA, USA
industry
Biotechnology
Size
11-50 employees
Stage
Other
founded in
2023
Shinobi Therapeutics is developing a new class of hypoimmune CD8AB iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
Something looks off?Open jobs at Shinobi Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.